LSHTM launches new centre of innovation to tackle antimicrobial resistance and tuberculosis

  10 July 2021

The London School of Hygiene & Tropical Medicine’s (LSHTM) research into tackling antimicrobial resistance and tuberculosis has been boosted through a new partnership with Johnson & Johnson.

LSHTM will host the inaugural J&J Center for Global Health Discovery (J&J CGHD). It marks the start of a new network of unique research partnerships between Johnson & Johnson and leading academic institutions to accelerate research into major global health challenges.

The J&J CGHD will advance the critical, early-stage discovery and exploratory science needed to develop potentially lifesaving innovations to address diseases that disproportionately impact the world’s poorest and most vulnerable people.

Further reading: LSHTM
Author(s): LSHTM
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!